Modulation of B-cell receptor and microenvironment signaling by a guanine exchange factor in B-cell malignancies

被引:2
作者
Liao, Wei [1 ]
Sharma, Sanjai [1 ]
机构
[1] UCLA Sch Med, Greater Los Angeles VA Healthcare Ctr, Div Hematol Oncol, Los Angeles, CA USA
关键词
CHRONIC LYMPHOCYTIC-LEUKEMIA; TYROSINE KINASE; BONE-MARROW; THERAPEUTIC TARGET; DOWN-REGULATION; EXPRESSION; ZAP-70; APOPTOSIS; OVEREXPRESSION; ERK;
D O I
10.20892/j.issn.2095-3941.2016.0026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) cells over-express a guanine exchange factor (GEF), Rasgrf-1. This GEF increases active Ras as it catalyzes the removal of GDP from Ras so that GTP can bind and activate Ras. This study aims to study the mechanism of action of Rasgrf-1 in B-cell malignancies. Methods: N-terminus truncated Rasgrf-1 variants have a higher GEF activity as compared to the full-length transcript therefore a MCL cell line with stable over-expression of truncated Rasgrf-1 was established. The B-cell receptor (BCR) and chemokine signaling pathways were compared in the Rasgrf-1 over-expressing and a control transfected cell line. Results: Cells over-expressing truncated form of Rasgrf-1 have a higher proliferative rate as compared to control transfected cells. BCR was activated by lower concentrations of anti-IgM antibody in Rasgrf-1 over-expressing cells as compared to control cells indicating that these cells are more sensitive to BCR signaling. BCR signaling also phosphorylates Rasgrf-1 that further increases its GEF function and amplifies BCR signaling. This activation of Rasgrf-1 in over-expressing cells resulted in a higher expression of phospho-ERK, AKT, BTK and PKC-alpha as compared to control cells. Besides BCR, Rasgrf-1 over-expressing cells were also more sensitive to microenvironment stimuli as determined by resistance to apoptosis, chemotaxis and ERK pathway activation. Conclusions: This GEF protein sensitizes B-cells to BCR and chemokine mediated signaling and also upregulates a number of other signaling pathways which promotes growth and survival of these cells.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 45 条
  • [1] Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen
    Bailon, Elvira
    Ugarte-Berzal, Estefania
    Amigo-Jimenez, Irene
    Van den Steen, Philippe
    Opdenakker, Ghislain
    Garcia-Marco, Jose A.
    Garcia-Pardo, Angeles
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2014, 96 (02) : 185 - 199
  • [2] The N-terminal moiety of CDC25(Mm), a GDP/GTP exchange factor of Ras proteins, controls the activity of the catalytic domain - Modulation by calmodulin and calpain
    Baouz, S
    Jacquet, E
    Bernardi, A
    Parmeggiani, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) : 6671 - 6676
  • [3] GEFs and GAPs: Critical elements in the control of small G proteins
    Bos, Johannes L.
    Rehmann, Holger
    Wittinghofer, Alfred
    [J]. CELL, 2007, 129 (05) : 865 - 877
  • [4] Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
    Buchner, Maike
    Fuchs, Simon
    Prinz, Gabriele
    Pfeifer, Dietmar
    Bartholome, Kilian
    Burger, Meike
    Chevalier, Nina
    Vallat, Laurent
    Timmer, Jens
    Gribben, John G.
    Jumaa, Hassan
    Veelken, Hendrik
    Dierks, Christine
    Zirlik, Katja
    [J]. CANCER RESEARCH, 2009, 69 (13) : 5424 - 5432
  • [5] Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia
    Buerkle, Andrea
    Niedermeier, Matthias
    Schmitt-Graff, Annette
    Wierda, William G.
    Keating, Michael J.
    Burger, Jan A.
    [J]. BLOOD, 2007, 110 (09) : 3316 - 3325
  • [6] Burger JA, 2000, BLOOD, V96, P2655
  • [7] Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells
    Burger, JA
    Kipps, TJ
    [J]. LEUKEMIA & LYMPHOMA, 2002, 43 (03) : 461 - 466
  • [8] The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies
    Burger, Jan A.
    Gribben, John G.
    [J]. SEMINARS IN CANCER BIOLOGY, 2014, 24 : 71 - 81
  • [9] The microenvironment in mature B-cell malignancies: a target for new treatment strategies
    Burger, Jan A.
    Ghia, Paolo
    Rosenwald, Andreas
    Caligaris-Cappio, Federico
    [J]. BLOOD, 2009, 114 (16) : 3367 - 3375
  • [10] Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
    Byrd, John C.
    Furman, Richard R.
    Coutre, Steven E.
    Flinn, Ian W.
    Burger, Jan A.
    Blum, Kristie A.
    Grant, Barbara
    Sharman, Jeff P.
    Coleman, Morton
    Wierda, William G.
    Jones, Jeffrey A.
    Zhao, Weiqiang
    Heerema, Nyla A.
    Johnson, Amy J.
    Sukbuntherng, Juthamas
    Chang, Betty Y.
    Clow, Fong
    Hedrick, Eric
    Buggy, Joseph J.
    James, Danelle F.
    O'Brien, Susan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (01) : 32 - 42